Molecular characterization of BRCA1 and BRCA2 genes in breast cancer patients under 40 years-old or with familiar cancer history

Molecular characterization of BRCA1 and BRCA2 genes in breast cancer patients under 40 years-old or with familiar cancer history

Bibliographic Details
Main Authors:	Dueñas-Gonzalez Alfonso, Hernandez Olga, Camargo Vanessa, Chayeb Lucia, Millan Silvia
Format:	Article
Language:	English
Published:	BMC 2007-02-01
Series:	BMC Cancer

Similar Items

Experience in treating BRCA-associated breast cancer. The BRCA-history of a family
by: A. V. Sultanbaev, et al.
Published: (2021-08-01)

Analysis of BRCA1 and BRCA2 mutations in Brazilian breast cancer patients with positive family history
by: Rozany Mucha Dufloth, et al.

Detection of BRCA1and BRCA2 mutation for Breast Cancer in Sample of Iraqi Women above 40 Years
by: Baghdad Science Journal
Published: (2010-03-01)

Risk assessment for hereditary breast cancer: BRCA1 and BRCA2
by: Kendra-Ann I. Seenandan-Sookdeo, et al.
Published: (2010-08-01)

LOSS OF HETEROZYGOSITY IN THE BRCA1 AND BRCA2 LOCUS IN BREAST CANCER
by: M. M. Tsyganov, et al.
Published: (2020-07-01)

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
by: Ellen Warner
Published: (2018-11-01)

Risk assessment for hereditary breast cancer: BRCA1 and BRCA2
by: Kendra-Ann I. Seenandan-Sookdeo, et al.
Published: (2010-07-01)

BRCA1 and BRCA2 and Inherited Predisposition to Breast and Ovarian Cancers
by: Patricia N. Tonin
Published: (2002-12-01)

Comparing Prognosis for <i>BRCA1</i>, <i>BRCA2</i>, and Non-BRCA Breast Cancer
by: Pedro Antunes Meireles, et al.
Published: (2023-12-01)

BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome
by: Ingrid Petroni Ewald, et al.
Published: (2016-06-01)

BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome
by: Ingrid Petroni Ewald, et al.
Published: (2016-06-01)

Predisposición genética para el cáncer de mama: genes BRCA1 y BRCA2 Genetic predisposition for breast cancer: BRCA1 and BRCA2 genes
by: Steven A Narod, et al.
Published: (2011-10-01)

BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients
by: Yinmei Zhang, et al.
Published: (2024-01-01)

Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru
by: Yomali Ferreyra, et al.
Published: (2023-08-01)

Investigating the Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients with Breast Cancer
by: Mohammad Hassan Tajadini, et al.
Published: (2013-02-01)

BRCA1 and BRCA2 Genetic Testing in Breast and/or Ovarian Cancer Families in Iran
by: Fatemeh Keshavarzi, et al.
Published: (2010-01-01)

Prevalance of <it>BRCA1</it> and <it>BRCA2</it> mutations in familial breast cancer patients in Lebanon
by: Jalkh Nadine, et al.
Published: (2012-06-01)

BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family history.
by: Gaik Theng Toh, et al.
Published: (2008-04-01)

Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation?
by: Emiroglu S, et al.
Published: (2023-02-01)

Role of BRCA 1 и BRCA 2 gene mutations in the occurrence of male breast cancer
by: A. V. Bykova, et al.
Published: (2014-07-01)

Preferences for breast cancer prevention among women with a BRCA1 or BRCA2 mutation
by: Carol A. Mansfield, et al.
Published: (2020-09-01)

BRCA1 and BRCA2 mutations in Iranian breast cancer patients: A systematic review
by: Hossein Neamatzadeh, et al.
Published: (2015-01-01)

Prevalence of <it>BRCA1 </it>and <it>BRCA2 </it>mutations in unselected breast cancer patients from Greece
by: Koumpis Chrissovaladis, et al.
Published: (2011-11-01)

Multifocal breast cancers are more prevalent in BRCA2 versus BRCA1 mutation carriers
by: Alan D McCrorie, et al.
Published: (2020-04-01)

MANAGEMENT OF BREAST CANCER WITH BRCA GENE MUTATION
by: I Wayan Ari Sumardika, et al.
Published: (2013-09-01)

Prostate Cancer: Germline Mutations in BRCA1 and BRCA2
by: Pankaja Umarane, et al.
Published: (2023-03-01)

BRCA1 mutations in women with familial or early-onset breast cancer and BRCA2 mutations in familial cancer in Estonia
by: Tamboom Kristiina, et al.
Published: (2010-04-01)

The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis
by: Katie Lin, et al.
Published: (2022-06-01)

BRCA1, BRCA2 mutations and the association with the clinicopathological characteristics of women with early-onset breast cancer
by: Ghazali, Mohamad Bazli
Published: (2014)

Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort
by: Li, J, et al.
Published: (2018)

Molecular profiling of BRCA1 and BRCA2 genes in Turkish patients with early-onset breast cancer
by: Taner Karakaya, et al.
Published: (2023-10-01)

BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers
by: Osman K., et al.
Published: (2022-12-01)

Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients
by: Yunuo Zhang, et al.
Published: (2022-08-01)

Mutational Analysis of BRCA1 and BRCA2 Genes in Breast Cancer Patients from Eastern Sicily
by: Stella S, et al.
Published: (2022-04-01)

Large genomic rearrangements in BRCA1 and BRCA2 genes in breast and ovarian cancer families in Poland
by: Bielecka Helena, et al.
Published: (2012-04-01)

The contribution of large genomic rearrangements in BRCA1 and BRCA2 to South African familial breast cancer
by: Nerina C. van der Merwe, et al.
Published: (2020-05-01)

Large genomic rearrangements in BRCA1 and BRCA2 genes in breast and ovarian cancer families in Poland
by: Bielecka Helena, et al.
Published: (2012-01-01)

Sequence Variants of BRCA1 and BRCA2 Genes in Four Iranian Families with Breast and Ovarian Cancer
by: F Keshavarzi, et al.
Published: (2011-06-01)

Sequence Variants of BRCA1 and BRCA2 Genes in Four Iranian Families with Breast and Ovarian Cancer
by: F Keshavarzi, et al.
Published: (2011-06-01)

Beyond breast and ovarian cancers: PARP inhibitors for BRCA mutation-associated and BRCA-like solid tumors
by: Ciara C. O'Sullivan, et al.
Published: (2014-02-01)